Up-to-date Analyst's Assessments: ConocoPhillips (COP), Argos Therapeutics, Inc. (ARGS)
On November 1 Scotiabank held the stock rating at "Buy" projecting a price of $53.00. ConocoPhillips presently has a consensus rating of "Buy" and an average target price of $55.37. The correct version of this story can be accessed at https://stocknewstimes.com/2017/11/16/conocophillips-cop-pt-set-at-58-00-by-royal-bank-of-canada.html. Consulte Mais Informação